Publications by authors named "Caleb Richard"
Objective: To examine the frequency and rate at which transfeminine patients receive prostate-specific antigen testing compared to a matched cisgender cohort.
Methods: Patients with prostates who had encounters in our health system, are currently age 46 or older, and who are alive were included in our study. Transfeminine patients were identified through diagnosis codes and chart review.
Article Synopsis
- This study evaluated cancer control outcomes in prostate cancer patients with clinically positive nodal involvement, comparing surgery with radiation while considering other causes of death.
- Researchers analyzed data from the SEER database for patients diagnosed from 2004 to 2017, using advanced statistical methods to adjust for differences in treatment and mortality risk.
- Findings indicated that, after 10 years, patients treated with radiation had significantly higher cancer-specific mortality rates (27.6%) compared to those treated with surgery (18.1%), highlighting the advantages of surgical intervention.
Article Synopsis
- This study analyzed how cannabis use disorder (CUD) affects hospitalized patients undergoing urologic cancer surgeries, focusing on complications, length of stay (LOS), and inpatient costs (IC) from 2003 to 2014.
- The findings revealed that the rate of CUD among patients increased significantly, with those affected being younger, more likely male, and from lower-income backgrounds, but CUD did not correlate with higher complication rates.
- However, patients with CUD did experience longer hospital stays and higher costs, suggesting a need for further research on managing LOS and IC for these individuals.
Article Synopsis
- This study examined prostate cancer-specific mortality (PCSM) among Black and White men by analyzing their other-cause mortality (OCM) risk to better understand healthcare access disparities.
- Researchers used a large patient database from 2004 to 2009, matching Black and White men with similar OCM risks for comparison.
- The findings revealed that when accounting for OCM risk, Black and White patients had similar rates of PCSM, suggesting that race did not significantly influence cancer survival rates at the population level.